Derisking Academic Science: The Unmet Need

2:30 PM - 3:45 PM, Monday, June 3,2019 ・ 112AB, Level 100
Academic science is arguably the greatest source of innovation in our ecosystem, yet faces considerable challenges when considering the transition from the lab to early stage company formation. It’s too early for traditional venture, yet there are few options for securing capital, resources and capabilities to advance this early science. This panel discussion will bring together experts with fresh approaches to de-risking academic science on the path towards value creation through early stage company formation leading to partnering opportunities.
Speakers
photo
CSO
Blavatnik Biomedical Accelerator, Harvard University
photo
Executive Director
Chicago Biomedical Consortium
photo
Assistant Dean, Therapeutics Alliances
NYU Langone Health
photo
Sr Director, Strategic Academic Alliances, Center for External Innovation
Takeda